781 top medical experts on Bone Marrow Diseases across 47 countries and 37 U.S. states, including 684 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Bone Marrow Diseases: Diseases involving the bone marrow.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hematologic Diseases (2,132) and Narrower Categories: Bone Marrow Failure Disorders (506), Bone Marrow Neoplasms (3,166), Myelodysplastic-Myeloproliferative Diseases (814), Myelodysplastic Syndromes (4,098), Myeloproliferative Disorders (3,110).
  4. Clinical Trials ClinicalTrials.gov : at least 180 including 11 Active, 79 Completed, 34 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Pulsipher, Michael A   Pediatric Hematology-Oncology   Google Publications
    Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, University of Southern California, Los Angeles, California. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Medical school: Stanford University School of Medicine (MD, 1990)
    Medicare Accepted
    Disclosed payments in 2021 from 7 biomedical companies, totalling $6,988.36, including $6,855.99 from  Novartis Pharmaceuticals Corporation
    Subjects: Anemia, Aplastic; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Long Term Adverse Effects; Anemia, Diamond-Blackfan
    Categories: Therapy; Diagnosis; Mortality; Adverse Effects; Etiology; Methods
    Peripheral-blood stem cells versus bone marrow from unrelated donors. (2012)
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)

  2. Guermazi, Ali   Diagnostic Radiology  Google Publications
    Boston University School of Medicine, Boston, Massachusetts.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 50 biomedical companies, totalling $763,790, including $754,765 from  PFIZER INC.
    Subjects: Osteoarthritis, Knee; Knee Joint; Cartilage, Articular; Magnetic Resonance Imaging; Bone Marrow
    Categories: Pathology; Diagnostic Imaging; Methods; Diagnosis; Epidemiology; Complications
    Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. (2016)
    Meniscal pathology on MRI increases the risk for both incident and enlarging subchondral bone marrow lesions of the knee: the MOST Study. (2010)

  3. Felson, David T   Rheumatology   Google Publications
    Boston University School of Medicine, Boston, Massachusetts, United States.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Johns Hopkins University School of Medicine (MD, 1978)
    Medicare Accepted
    Subjects: Osteoarthritis, Knee; Knee Joint; Cartilage, Articular; Magnetic Resonance Imaging; Bone Marrow
    Categories: Pathology; Diagnostic Imaging; Therapy; Methods; Physiopathology; Diagnosis
    A randomised trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions. (2015)
    Meniscal pathology on MRI increases the risk for both incident and enlarging subchondral bone marrow lesions of the knee: the MOST Study. (2010)

  4. Young, Neal S   Hematology   ClinicalTrials.gov Google Publications
    Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Telomere; Bone Marrow; T-Lymphocytes
    Categories: Genetics; Immunology; Pathology; Drug Therapy; Diagnosis; Pharmacology
    Danazol Treatment for Telomere Diseases. (2016)
    Bone marrow failure and the telomeropathies. (2014)

  5. Savage, Sharon A   Pediatric Hematology-Oncology   Google Publications
    Clinical Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Neoplasms; Anemia, Diamond-Blackfan; Dyskeratosis Congenita
    Categories: Diagnosis; Complications; Epidemiology; Etiology; Genetics; Physiopathology
    Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. (2018)
    Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. (2010)

  6. Woolfrey, Ann E   Pediatric Hematology-Oncology  Google Publications
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Hematopoietic Stem Cell Transplantation; Anemia, Aplastic; Autoimmune Diseases; Bone Marrow Transplantation; Busulfan
    Categories: Mortality; Therapy; Methods; Analogs & Derivatives
    Peripheral-blood stem cells versus bone marrow from unrelated donors. (2012)
    The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. (2019)

  7. Alter, Blanche P   Pediatric Hematology-Oncology   Google Publications
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Hematopoietic Stem Cell Transplantation; Fanconi Anemia; Long Term Adverse Effects
    Categories: Diagnosis; Complications; Therapy; Epidemiology; Etiology; Genetics
    Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. (2018)
    Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. (2010)

  8. Shimamura, Akiko   Pediatric Hematology-Oncology   Google Publications
    Dana-Farber/Boston Childrens Cancer and Blood Disorders Center, Boston, Massachusetts.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Subjects: Exocrine Pancreatic Insufficiency; Lipomatosis; Ribosomes; Anemia, Macrocytic; Neutropenia
    Categories: Genetics; Metabolism; Diagnosis; Pathology; Therapy; Etiology
    Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. (2017)
    Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. (2011)

  9. Westervelt, Peter   Medical Oncology  Google Publications
    Bone Marrow Transplant and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Washington University School of Medicine (MD, 1992)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 84/100
    Disclosed payments from biomedical company (PFIZER INTERNATIONAL LLC) in 2021 for $1,480
    Subjects: Leukemia; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Cardiomyopathies; Cord Blood Stem Cell Transplantation
    Categories: Therapy; Adverse Effects; Chemically Induced; Mortality; Methods; Pathology
    Peripheral-blood stem cells versus bone marrow from unrelated donors. (2012)
    Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation. (2017)

  10. Anasetti, Claudio   Medical Oncology   Google Publications
    H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. .
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 13 biomedical companies, totalling $12,598.75, including $11,098.75 from  Kite Pharma, Inc.
    Subjects: Bone Marrow Transplantation; Leukemia; Peripheral Blood Stem Cell Transplantation; Unrelated Donors
    Categories: Mortality; Therapy
    Peripheral-blood stem cells versus bone marrow from unrelated donors. (2012)
    Peripheral-blood versus bone marrow stem cells. (2013)

  11. Lipton, Jeffrey M   Pediatric Hematology-Oncology  Google Publications
    Division of Hematology/Oncology and Stem Cell Transplantation, Hofstra Northwell School of Medicine, Feinstein Institute for Medical Research, Cohen Childrens Medical Center, New Hyde Park, New York.
    Physician  Highly Published  Guideline  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 88.9/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $2,975, including $2,825 from  Celgene Corporation
    Subjects: Anemia, Aplastic; Exocrine Pancreatic Insufficiency; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Lipomatosis
    Categories: Genetics; Diagnosis; Therapy; Methods
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)
    Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation. (2017)

  12. Myers, Kasiani C   Pediatric Hematology-Oncology   Google Publications
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio.
    Physician  Highly Cited  Highly Published 
    Subjects: Exocrine Pancreatic Insufficiency; Lipomatosis; Neutropenia; Ventricular Dysfunction, Left; Dwarfism
    Categories: Genetics; Diagnosis; Complications; Therapy; Diagnostic Imaging; Congenital
    Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. (2017)
    Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. (2014)

  13. Sorror, Mohamed L   Medical Oncology  Google Publications
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100
    Subjects: Hematopoietic Stem Cell Transplantation; Anemia, Aplastic; Autoimmune Diseases; Graft vs Host Disease; Hemoglobinuria, Paroxysmal
    Categories: Mortality; Therapy; Adverse Effects
    Reduced mortality after allogeneic hematopoietic-cell transplantation. (2010)
    The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. (2019)

  14. Mehta, Parinda A   Pediatric Hematology-Oncology  Google Publications
    Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
    Physician  Highly Published  Guideline 
    Subjects: Anemia, Aplastic; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Anemia, Diamond-Blackfan; Bone Marrow Transplantation
    Categories: Diagnosis; Genetics; Therapy; Methods; Metabolism; Surgery
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)
    Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation. (2017)

  15. Jazrawi, Laith M   Sports Medicine  Google Publications
    3 Department of Radiology, NYU Langone Medical Center, New York, NY.
    Physician  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86/100
    Disclosed payments in 2021 from 4 biomedical companies, totalling $1,260.29, including $1,200 from  Gotham Surgical Solutions & Devices, Inc.
    Subjects: Edema; Calcium Phosphates; Osteoarthritis; Arthroplasty, Subchondral; Magnetic Resonance Imaging
    Categories: Drug Therapy; Pathology; Administration & Dosage; Complications; Diagnostic Imaging; Etiology
    Subchondral Calcium Phosphate is Ineffective for Bone Marrow Edema Lesions in Adults With Advanced Osteoarthritis. (2015)
    Bone Marrow Edema: Chronic Bone Marrow Lesions of the Knee and the Association with Osteoarthritis. (2016)

  16. Dietz, Andrew C   Pediatric Hematology-Oncology   Google Publications
    Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, University of Southern California, Los Angeles, California. Electronic address: . Top Hospital
    Physician  Guideline 
    Subjects: Hematopoietic Stem Cell Transplantation; Long Term Adverse Effects; Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Anemia, Diamond-Blackfan
    Categories: Diagnosis; Therapy; Adverse Effects; Etiology; Methods
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)
    The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. (2017)

  17. Giri, Neelam   Pediatric Hematology-Oncology   Google Publications
    Clinical Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Neoplasms; Fanconi Anemia; Abortion, Spontaneous
    Categories: Complications; Diagnosis; Epidemiology; Etiology; Physiopathology
    Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. (2018)
    Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. (2010)

  18. Duncan, Christine N   Pediatric Hematology-Oncology  Google Publications
    Dana-Farber/Boston Childrens Cancer and Blood Disorders Center, Boston, Massachusetts.
    Physician  Guideline 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $5,560, including $4,560 from  Omeros Corporation
    Subjects: Hematopoietic Stem Cell Transplantation; Long Term Adverse Effects; Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Anemia, Diamond-Blackfan
    Categories: Diagnosis; Therapy; Adverse Effects; Etiology; Methods
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)
    The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. (2017)

  19. Vlachos, Adrianna   Pediatric Hematology-Oncology  Google Publications
    Division of Hematology/Oncology and Stem Cell Transplantation, Hofstra Northwell School of Medicine, Feinstein Institute for Medical Research, Cohen Childrens Medical Center, New Hyde Park, New York.
    Physician  Guideline  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 81/100
    Subjects: Anemia, Aplastic; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Alleles; Anemia, Diamond-Blackfan
    Categories: Diagnosis; Genetics; Therapy; Methods
    Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. (2017)
    Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation. (2017)

  20. Davies, Stella M   Pediatric Hematology-Oncology  Google Publications
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio.
    Physician  Highly Published 
    Subjects: Exocrine Pancreatic Insufficiency; Lipomatosis; Ventricular Dysfunction, Left; Echocardiography; Genetic Diseases, Inborn
    Categories: Diagnosis; Therapy; Complications; Diagnostic Imaging; Congenital; Etiology
    Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. (2014)
    Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. (2013)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);